Literature DB >> 22236004

Utility of peripheral blood B cell subsets analysis in common variable immunodeficiency.

M Al Kindi1, J Mundy, T Sullivan, W Smith, F Kette, A Smith, R Heddle, P Hissaria.   

Abstract

Abnormalities in peripheral blood B cell subsets have been identified in common variable immunodeficiency (CVID) patients and classification systems based upon their numbers have been proposed to predict the clinical features. We analysed B lymphocyte subsets by multi-colour flow cytometry (MFC) in a cohort of well-characterized CVID patients to look at their clinical relevance and validate the published association of different classification criteria (Freiburg, Paris and Euroclass) with clinical manifestations. CVID patients had a reduced proportion of total and switched memory B cells (MBC, swMBC) compared to normal controls (P < 0·0006). Patients classified in Freiburg Ia had a higher prevalence of granulomatous diseases (P = 0·0034). The previously published associations with autoimmune diseases could not be confirmed. The Euroclass classification was not predictive of clinical phenotypes. The absolute numbers of all B cell subsets were reduced in CVID patients compared to controls. There was a significant linear correlation between low absolute total B cells and MBC with granulomatous disease (P < 0·05) and a trend towards lower B cells in patients with autoimmune diseases (P = 0·07). Absolute number of different B cell subsets may be more meaningful than their relative percentages in assessing the risk of granulomatous diseases and possibly autoimmunity.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236004      PMCID: PMC3278694          DOI: 10.1111/j.1365-2249.2011.04507.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Active vaccination in patients with common variable immunodeficiency (CVID).

Authors:  S Goldacker; R Draeger; K Warnatz; D Huzly; U Salzer; J Thiel; H Eibel; M Schlesier; H H Peter
Journal:  Clin Immunol       Date:  2007-06-29       Impact factor: 3.969

Review 3.  Common variable immunodeficiency: how many diseases?

Authors:  G P Spickett; J Farrant; M E North; J G Zhang; L Morgan; A D Webster
Journal:  Immunol Today       Date:  1997-07

4.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

6.  Flowcytometric phenotyping of common variable immunodeficiency.

Authors:  Klaus Warnatz; Michael Schlesier
Journal:  Cytometry B Clin Cytom       Date:  2008-09       Impact factor: 3.058

7.  B-cell maturation defects in common variable immunodeficiency and association with clinical features.

Authors:  Lucinda J Berglund; Sue W J Wong; David A Fulcher
Journal:  Pathology       Date:  2008-04       Impact factor: 5.306

8.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

9.  Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency.

Authors:  Paula Jane Busse; Samiya Razvi; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2002-06       Impact factor: 10.793

10.  Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry.

Authors:  Nima Rezaei; Asghar Aghamohammadi; Mostafa Moin; Zahra Pourpak; Masoud Movahedi; Mohammad Gharagozlou; Lida Atarod; Bahram Mirsaeid Ghazi; Anna Isaeian; Maryam Mahmoudi; Kamran Abolmaali; Davoud Mansouri; Saba Arshi; Naser Javaher Tarash; Roya Sherkat; Hedayat Akbari; Reza Amin; Abdolvahab Alborzi; Sara Kashef; Reza Farid; Iraj Mohammadzadeh; Mehrnaz Sadeghi Shabestari; Mohammad Nabavi; Abolhassan Farhoudi
Journal:  J Clin Immunol       Date:  2006-10-06       Impact factor: 8.542

View more
  11 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives.

Authors:  Delfien J A Bogaert; Marieke De Bruyne; Veronique Debacker; Pauline Depuydt; Katleen De Preter; Carolien Bonroy; Jan Philippé; Victoria Bordon; Bart N Lambrecht; Tessa Kerre; Andrea Cerutti; Karim Y Vermaelen; Filomeen Haerynck; Melissa Dullaers
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

3.  Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiency.

Authors:  V Ballegaard; H Permin; T L Katzenstein; H V Marquart; L Schejbel
Journal:  J Clin Immunol       Date:  2013-05-07       Impact factor: 8.317

4.  Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.

Authors:  Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2014-05-02       Impact factor: 8.317

Review 5.  Common Variable Immunodeficiency and Liver Involvement.

Authors:  Junmin Song; Ana Lleo; Guo Xiang Yang; Weici Zhang; Christopher L Bowlus; M Eric Gershwin; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

6.  Lymphocyte Subgroups and KREC Numbers in Common Variable Immunodeficiency: A Single Center Study.

Authors:  Ismail Yaz; Begum Ozbek; Yuk Yin Ng; Pinar Gur Cetinkaya; Sevil Oskay Halacli; Cagman Tan; Merve Kasikci; Can Kosukcu; Ilhan Tezcan; Deniz Cagdas
Journal:  J Clin Immunol       Date:  2020-02-14       Impact factor: 8.317

7.  Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.

Authors:  Necil Kutukculer; Nesrin Gulez; Neslihan E Karaca; Guzide Aksu; Afig Berdeli
Journal:  J Clin Immunol       Date:  2012-06-15       Impact factor: 8.317

8.  Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients.

Authors:  G K Wong; S Goldacker; C Winterhalter; B Grimbacher; H Chapel; M Lucas; D Alecsandru; D McEwen; I Quinti; H Martini; C Milito; R E Schmidt; D Ernst; T Espanol; A Vidaller; J Carbone; E Fernandez-Cruz; V Lougaris; A Plebani; N Kutukculer; L I Gonzalez-Granado; R Contreras; S Kiani-Alikhan; M A A Ibrahim; J Litzman; A Jones; H B Gaspar; L Hammarstrom; U Baumann; K Warnatz; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

Review 9.  Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.

Authors:  Laurent Simonin; Elisabeth Pasquier; Christophe Leroyer; Divi Cornec; Julie Lemerle; Boutahar Bendaoud; Sophie Hillion; Jacques-Olivier Pers; Francis Couturaud; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 10.  Chipping away at a mountain: genomic studies in common variable immunodeficiency.

Authors:  Michael D Keller; Soma Jyonouchi
Journal:  Autoimmun Rev       Date:  2012-11-29       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.